Rankings
▼
Calendar
FATE FY 2020 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$142M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+194.3% YoY
Gross Profit
-$94M
-299.6% margin
Operating Income
-$128M
-407.5% margin
Net Income
-$173M
-551.6% margin
EPS (Diluted)
$-2.10
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$44M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$622M
Total Liabilities
$238M
Stockholders' Equity
$384M
Cash & Equivalents
$167M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$11M
+194.3%
Gross Profit
-$94M
$11M
-981.9%
Operating Income
-$128M
-$101M
-27.2%
Net Income
-$173M
-$98M
-76.7%
← Q4 2019
All Quarters
Q1 2020 →